TFS Capital’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-10,788
Closed -$261K 1018
2015
Q4
$261K Buy
+10,788
New +$270K 0.03% 547
2015
Q2
Sell
-12,814
Closed -$287K 936
2015
Q1
$287K Buy
+12,814
New +$246K 0.03% 702
2014
Q3
Sell
-1,302
Closed -$21K 1065
2014
Q2
$21K Sell
1,302
-18,689
-93% -$282K ﹤0.01% 1088
2014
Q1
$361K Sell
19,991
-45,043
-69% -$835K 0.02% 910
2013
Q4
$1.27M Buy
+65,034
New +$952K 0.06% 467
2013
Q3
Sell
-5,349
Closed -$59K 1471
2013
Q2
$59K Buy
+5,349
New +$113K ﹤0.01% 1453

Other funds holding DVAX

TFS Capital's DVAX Position: Q1 2016 in Review

TFS Capital sold out of Dynavax Technologies (DVAX) in Q1 2016, closing a stake of 10,788 shares — an estimated $261K sold.

TFS Capital first reported a position in DVAX in Q2 2013 and held it in 6 quarters. The position peaked at $1.27M in Q4 2013. 130 funds tracked by Wall St. Rank hold DVAX as of Q1 2016.

  • TFS Capital reported no remaining Dynavax Technologies position as of Q1 2016 after selling out during the quarter.
  • TFS Capital sold 10,788 Dynavax Technologies shares in Q1 2016, an estimated $261K.
  • TFS Capital first reported a position in Dynavax Technologies in Q2 2013 and held it in 6 quarters.
  • TFS Capital's Dynavax Technologies position peaked at $1.27M in Q4 2013.
  • 130 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2016.

Based on TFS Capital's 13F filing for Q1 2016, filed 10 May 2016.